Publication | Closed Access

Neurotoxic and neuroprotective effects of the glutamate transporter inhibitor dl-threo-beta-benzyloxyaspartate (dl-TBOA) during physiological and ischemia-like conditions

Cerebral Vascular RegulationNeurophysiologyMedicineNeuropharmacologyBrain InjuryNeurologyNeurosciencePharmacotherapyNeuroprotectionCerebral Blood FlowPharmacologyNeurochemistryIschemia-like ConditionsIschemic SyndromeSocial SciencesReperfusion InjuryNeuroprotective Effects